Examples of 'incretin' in a sentence
Meaning of "incretin"
Incretin is a type of hormone that helps to regulate blood sugar levels in the body
Show more definitions
- A gastrointestinal hormone causing an increase in the amount of insulin released from the beta cells of the islets of Langerhans after eating, even before blood glucose levels become elevated.
How to use "incretin" in a sentence
Basic
Advanced
incretin
Exenatide belonging to the group of incretin mimetics.
Incretin mimetics decrease gastric motility and cause nausea.
Antidiabetics which affect the incretin system.
Incretin hormones are secreted by intestinal cells in response to nutrient ingestion.
It is suspected that these cells are involved in incretin functions.
Both incretin hormones are involved in the physiological regulation of glucose homeostasis.
Method of restoring the incretin effect.
He found that incretin therapy made certain pancreas cells multiply.
It works by blocking the breakdown of incretin hormones in the body.
The incretin effect.
It works by increasing the amount of incretin released by the intestine.
Incretin receptor signaling exerts physiologically relevant action critical for glucose homeostasis.
Sitagliptin blocks the breakdown of incretin hormones in the body.
The incretin effect was assessed by isoglycemic clamp technique isoglycemic intravenous glucose infusion test.
It works by increasing the proportion of incretin released by the intestine.
See also
Some of its major functions include regulating food intake and secretion of insulin and incretin.
There is evidence that incretin mimetic drugs may lead to pancreatitis.
Embodiments of such a combination can include therapeutically effective doses of incretin and biguanide compounds.
These results indicate that this incretin does not act completely on glycemic control.
In some aspects, the diabetes drug is insulin or an incretin mimetic.
It had also previously been thought that incretin therapies could promote pancreatic cancer.
GIP is an incretin that stimulates insulin secretion directly in a glucose dependent manner.
Sitagliptin works by increasing the amount of incretin released by the intestine.
Doctors will prescribe incretin mimetics for patients to take along with insulin injections.
This ingredient works by increasing the amount of incretin released by the intestine.
All incretin mimetics have the potential to cause it, a sudden onset of pancreatitis.
Type 2 diabetic patients have severely impaired incretin effect.
Januvia ( sitagliptin ) increases incretin levels which increases insulin synthesis and release.
In some embodiments, the additional therapeutic agent is an incretin mimetic.
Evidence points to incretin mimetic type-2 diabetes treatments as the culprit of these adverse reactions.
The glucose content of the blood is regulated by the hormones insulin, incretin and glucagon.
In patients with type 2 diabetes the incretin effect is reduced, contributing to impaired glycemic control.
However, these therapies fail to restore first-phase insulin release or the incretin effect.
Further, incretin hormones may improve insulin sensitivity and possibly increase islet cell neogenesis.
The administration of a selective k-receptor antagonist to a subject in need thereof restores the incretin effect.
To address the effects on incretin production, total GIP levels were measured.
The active substance in Byetta, exenatide, is an ‘ incretin mimetic.
GIP ( Glucosedependent Insulinotropic Polypeptide ) is an incretin that stimulates insulin secretion directly in a glucose-dependent manner.
DPP-4 inhibitors work by stopping the breakdown of incretin hormones.
GLP-1 is an incretin hormone that is released postprandially.
T2D patients have impaired incretin responses.
Examples of incretin mimetics include and are not limited to exenatide ( Byetta ® ).
The method according to claim 23, wherein the incretin mimetic is detected by a radioimmunoassay.
The other incretin hormone, GLP-1 is the most potent insulinotropic substance known.
DPP-4 is an enzyme that breaks down incretin hormones.
DPP-4 inhibitors increase active incretin levels by preventing the inactivation of endogenous incretins by DPP-4.
The DPP-4 inhibitors are a class of agents that act as incretin enhancers.
Direct incretin mimetics include such medicinal products as exenatide ( Byetta ), liraglutide ( Viktoza ), albiglutide and dulaglutide.
BYETTA exhibits many of the same effects as the human incretin hormone GLP-1.
The incretin function of GLP-1 is preserved in Diabetes.
